W. Lijfering

发表

Predictive value of factor VIII levels for recurrent venous thrombosis: results from the MEGA follow‐up study

S. Cessie, F. Rosendaal, S. Cannegieter, 2015, Journal of thrombosis and haemostasis : JTH.

Combined oral contraceptives: the risk of myocardial infarction and ischemic stroke.

A. Algra, T. Stijnen, O. Dekkers, 2015, The Cochrane database of systematic reviews.

Glucocorticoid use and risk of first and recurrent venous thromboembolism: self‐controlled case‐series and cohort study

S. le Cessie, O. Dekkers, F. Rosendaal, 2021, British journal of haematology.

Relationship between neighborhood socioeconomic status and venous thromboembolism: results from a population‐based study

S. Cannegieter, W. Lijfering, N. Wiersma, 2017, Journal of thrombosis and haemostasis : JTH.

Statin use in patients with nephrotic syndrome is associated with a lower risk of venous thromboembolism.

G. Navis, B. Mahmoodi, N. Veeger, 2011, Thrombosis research.

Statins and Risk of Bleeding: An Analysis to Evaluate Possible Bias Due to Prevalent Users and Healthy User Aspects.

P. Reitsma, S. le Cessie, F. Rosendaal, 2016, American journal of epidemiology.

Nutrition and venous thrombosis: An exercise in thinking about survivor bias

S. Cannegieter, W. Lijfering, 2018, Research and practice in thrombosis and haemostasis.

Switching from vitamin K antagonists to direct oral anticoagulants in non‐valvular atrial fibrillation patients: Does low time in therapeutic range affect persistence?

M. Kruip, S. Cannegieter, F. V. D. van der Meer, 2021, Journal of thrombosis and haemostasis : JTH.

The association between leptin concentration and blood coagulation: Results from the NEO study.

J. Jukema, R. de Mutsert, F. Rosendaal, 2020, Thrombosis research.

The risk of venous and arterial thrombosis in hyperhomocysteinemic subjects may be a result of elevated factor VIII levels

J. van der Meer, N. Veeger, W. Lijfering, 2007, Haematologica.

Methionine‐loading and random homocysteine tests have no added value in risk assessment for venous and arterial thrombosis

J. van der Meer, J. Brouwer, N. Veeger, 2007, Journal of thrombosis and haemostasis : JTH.

Interaction of Hereditary Thrombophilia and Traditional Cardiovascular Risk Factors on the Risk of Arterial Thromboembolism: Pooled Analysis of Four Family Cohort Studies

B. Mahmoodi, K. Hamulýak, J. T. ten Berg, 2016, Circulation. Cardiovascular genetics.

OP-EHEA210428_online 4126..4138

S. Cannegieter, W. Lijfering, V. Tichelaar, 2021 .

Major Bleeding Rates in Atrial Fibrillation Patients on Single, Dual, or Triple Antithrombotic Therapy: Results From a Nationwide Danish Cohort Study

H. Sørensen, O. Dekkers, S. Cannegieter, 2019, Circulation.

Objectives and Design of BLEEDS: A Cohort Study to Identify New Risk Factors and Predictors for Major Bleeding during Treatment with Vitamin K Antagonists

P. Reitsma, F. V. D. van der Meer, W. Lijfering, 2016, PloS one.

Perioperative Management in Patients Using Vitamin K Antagonists: Observational Cohort Study

F. V. D. van der Meer, J. Burggraaf, W. Lijfering, 2020, Thrombosis and Haemostasis.

Sex difference in risk of recurrent venous thrombosis and the risk profile for a second event

F. Rosendaal, S. Cannegieter, S. Christiansen, 2010, Journal of thrombosis and haemostasis : JTH.

Seasonal variation of venous thrombosis: a consecutive case series within studies from Leiden, Milan and Tromsø: reply to a rebuttal

F. Rosendaal, W. Lijfering, D. Ribeiro, 2013, Journal of Thrombosis and Haemostasis.

Short-term outpatient follow-up of COVID-19 patients: A multidisciplinary approach

M. Feltkamp, M. Schalij, P. Postmus, 2021, EClinicalMedicine.

Chronic kidney disease stages 1–3 increase the risk of venous thrombosis

F. Dekker, F. Rosendaal, R. Gansevoort, 2010, Journal of thrombosis and haemostasis : JTH.

Rise of levels of von Willebrand factor and factor VIII with age: Role of genetic and acquired risk factors.

F. Rosendaal, J. Eikenboom, S. Cannegieter, 2020, Thrombosis research.

Role of Routine Laboratory Tests in Assessing Risk of Recurrent Venous Thrombosis: Results from the MEGA Follow-Up Study

F. Rosendaal, S. Cannegieter, S. Rezende, 2018, Thrombosis and Haemostasis.

Risk of venous thrombosis in patients with chronic kidney disease: identification of high‐risk groups

F. Dekker, F. Rosendaal, G. Ocak, 2013, Journal of thrombosis and haemostasis : JTH.

Risk of recurrent venous thromboembolism in patients with HIV infection: A nationwide cohort study

P. Reiss, W. Bierman, F. Wit, 2020, PLoS medicine.

Causes and consequences of the opioid epidemic in the Netherlands: a population-based cohort study

A. Dahan, M. Bouvy, F. Rosendaal, 2020, Scientific Reports.

Increased risk of arterial thromboembolism after a prior episode of venous thromboembolism: results from the Prevention of REnal and Vascular ENd stage Disease (PREVEND) Study

H. Kluin-Nelemans, R. Gansevoort, B. Mahmoodi, 2012, British journal of haematology.

Rosuvastatin use improves measures of coagulation in patients with venous thrombosis

F. Rosendaal, F. Leebeek, M. Kruip, 2018, European heart journal.

Rosuvastatin use increases plasma fibrinolytic potential: a randomised clinical trial

J. Versmissen, T. van Gelder, F. Leebeek, 2020, British journal of haematology.

Revisiting the evidence for physical distancing, face masks, and eye protection

W. Lijfering, 2021, The Lancet.

Differential effect of statin use on coagulation markers: an active comparative analysis in the NEO study

J. Jukema, R. de Mutsert, F. Rosendaal, 2021, Thrombosis Journal.

Risk of Recurrent Venous Thrombosis in Homozygous Carriers and Double Heterozygous Carriers of Factor V Leiden and Prothrombin G20210A

M. Prins, H. Büller, J. van der Meer, 2010, Circulation.

Past provoking venous thrombosis risk situations on the risk of a recurrent thrombotic event: a cohort study.

F. Rosendaal, S. Barreto, S. Rezende, 2011, Thrombosis research.

Prediction of recurrent venous thrombosis in all patients with a first venous thrombotic event: The Leiden Thrombosis Recurrence Risk Prediction model (L-TRRiP)

S. le Cessie, J. Hansen, S. Braekkan, 2019, PLoS medicine.

Direct oral anticoagulant use and risk of perioperative bleeding: Evidence of absence or absence of evidence?

W. Lijfering, Y. Tichelaar, 2018, Research and practice in thrombosis and haemostasis.

Vitamin K1 in oral solution or tablets: a crossover trial and two randomized controlled trials to compare effects

S. Cessie, F. Rosendaal, W. Lijfering, 2014, Journal of thrombosis and haemostasis : JTH.

Risk of venous thrombosis in patients with major illnesses: results from the MEGA study

F. Dekker, F. Rosendaal, G. Ocak, 2013, Journal of thrombosis and haemostasis : JTH.

Pneumonia and risk of venous thrombosis: results from the MEGA study

F. Rosendaal, S. Cannegieter, A. van Hylckama Vlieg, 2012, Journal of thrombosis and haemostasis : JTH.

Association of apolipoproteins C-I, C-II, C-III and E with coagulation markers and venous thromboembolism risk

F. Rosendaal, A. Van der Laarse, S. Cannegieter, 2019, Clinical epidemiology.

Hyperhomocysteinemia and Risk of First Venous Thrombosis: The Influence of (Unmeasured) Confounding Factors

F. Rosendaal, M. den Heijer, S. Cannegieter, 2018, American journal of epidemiology.

High Soluble Thrombomodulin Is Associated with an Increased Risk of Major Bleeding during Treatment with Oral Anticoagulants: A Case–Cohort Study

P. Reitsma, S. Cannegieter, F. V. D. van der Meer, 2020, Thrombosis and Haemostasis.

Multi‐dose drug dispensing as a tool to improve medication adherence: A study in patients using vitamin K antagonists

P. Reitsma, S. Cannegieter, F. V. D. van der Meer, 2018, Pharmacoepidemiology and drug safety.

Chronic kidney disease stage 1-3 increases risk of venous thrombosis

F. Dekker, F. Rosendaal, G. Ocak, 2015 .

thrombosis in thrombophilic families men is explained by sex-specific risk factors at time of first venous A lower risk of recurrent venous thrombosis in women compared with

M. Prins, S. Middeldorp, N. Veeger, 2013 .

The relationship between DOAC levels and clinical outcomes: The measures tell the tale

W. Lijfering, L. Scheres, M. M. A. Toorop, 2020, Journal of thrombosis and haemostasis : JTH.

Association Between Hepatic Triglyceride Content and Coagulation Factors

H. Lamb, R. de Mutsert, F. Rosendaal, 2020, Arteriosclerosis, thrombosis, and vascular biology.

Glucose levels and diabetes are not associated with the risk of venous thrombosis: results from the MEGA case‐control study

F. Rosendaal, R. Li-Gao, S. Cannegieter, 2018, British journal of haematology.

The risk of venous thrombosis in women over 50 years old using oral contraception or postmenopausal hormone therapy

F. Rosendaal, S. Cannegieter, A. van Hylckama Vlieg, 2013, Journal of thrombosis and haemostasis : JTH.

Mild antithrombin deficiency and risk of recurrent venous thromboembolism: results from the MEGA follow‐up study

S. Cessie, F. Rosendaal, S. Cannegieter, 2018, Journal of thrombosis and haemostasis : JTH.

Statins in venous thrombosis: biochemical approaches to limiting vascular disease

F. Rosendaal, S. Cannegieter, W. Lijfering, 2021 .

Predicting the risk of recurrent venous thrombosis: What the future might bring

S. Cannegieter, J. F. Timp, W. Lijfering, 2019, Journal of thrombosis and haemostasis : JTH.

Direct oral anticoagulant use and subsequent start of proton pump inhibitors as proxy for gastric complaints

F. Rosendaal, F. Klok, M. Huisman, 2018, Pharmacoepidemiology and drug safety.

Link between co-trimoxazole and sudden death in patients receiving inhibitors of renin-angiotensin system could be due to confounding

W. Lijfering, H. Scheper, 2014, BMJ : British Medical Journal.

Platelet reactivity in patients with venous thrombosis who use rosuvastatin: a randomized controlled clinical trial

P. Reitsma, M. Kruip, S. Cannegieter, 2016, Journal of thrombosis and haemostasis : JTH.

The relationship between DOAC levels and clinical outcomes: The measures tell the tale–Response from original authors Lijfering et al

W. Lijfering, L. Scheres, M. M. A. Toorop, 2021, Journal of thrombosis and haemostasis : JTH.

The joint effect of genetic risk factors and different types of combined oral contraceptives on venous thrombosis risk

S. le Cessie, F. Rosendaal, S. Cannegieter, 2020, British journal of haematology.

A prospective cohort study on the absolute risks of venous thromboembolism and predictive value of screening asymptomatic relatives of patients with hereditary deficiencies of protein S, protein C or antithrombin

H. Kluin-Nelemans, B. Mahmoodi, J. van der Meer, 2010, Journal of thrombosis and haemostasis : JTH.

Risk of recurrent venous thromboembolism related to prior risk situations: re-evaluation of a cohort study with a longer follow-up

F. Rosendaal, S. Rezende, W. Lijfering, 2020, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Risk of recurrent venous thrombosis related to past provoking risk situations: follow-up of a cohort study

F. Rosendaal, S. Barreto, S. Rezende, 2013, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Epidemiology of recurrent venous thrombosis

F. Rosendaal, S. Barreto, S. Rezende, 2011, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

Rosuvastatin treatment decreases plasma procoagulant phospholipid activity after a VTE: A randomized controlled trial

J. Hansen, M. Kruip, S. Cannegieter, 2021, Journal of thrombosis and haemostasis : JTH.

Inter‐ and intra‐individual concentrations of direct oral anticoagulants: The KIDOAC study

M. Huisman, S. Cannegieter, F. V. D. van der Meer, 2021, Journal of thrombosis and haemostasis : JTH.

Risk prediction of recurrent venous thrombosis; where are we now and what can we add?

S. le Cessie, F. Rosendaal, S. Cannegieter, 2019, Journal of thrombosis and haemostasis : JTH.

Hyperhomocysteinaemia and the risk of recurrent venous thrombosis: results from the MEGA follow‐up study

F. Rosendaal, S. Cannegieter, A. van Hylckama Vlieg, 2019, British journal of haematology.

Lipid levels and risk of recurrent venous thrombosis: results from the MEGA follow‐up study

F. Rosendaal, S. Cannegieter, W. Lijfering, 2017, Journal of thrombosis and haemostasis : JTH.

Who is at high risk of recurrent venous thrombosis and do they really benefit from continuation of anticoagulation? Clinicians wield a double-edged sword that might cut nothing at all.

W. Lijfering, Y. Tichelaar, 2016, Thrombosis research.

The influence of prothrombotic laboratory abnormalities on the risk of recurrent venous thrombosis.

F. Rosendaal, S. Barreto, S. Rezende, 2012, Thrombosis research.

Clinical relevance of decreased free protein S levels: results from a retrospective family cohort study involving 1143 relatives.

J. van der Meer, A. Mulder, N. Veeger, 2009, Blood.

Measurement of coagulation factors during rivaroxaban and apixaban treatment: Results from two crossover trials

S. Middeldorp, S. Cannegieter, W. Lijfering, 2018, Research and practice in thrombosis and haemostasis.

2479 relatives absolute thrombotic risk for currently known thrombophilic defects in thrombosis: results from a retrospective family cohort study on Selective testing for thrombophilia in patients with first venous

M. Prins, H. Büller, S. Middeldorp, 2010 .

Selective testing for thrombophilia in patients with first venous thrombosis: results from a retrospective family cohort study on absolute thrombotic risk for currently known thrombophilic defects in 2479 relatives.

M. Prins, H. Büller, J. van der Meer, 2009, Blood.

Role of Obesity in the Etiology of Deep Vein Thrombosis and Pulmonary Embolism: Current Epidemiological Insights

J. Hansen, S. Braekkan, F. Rosendaal, 2013, Seminars in Thrombosis & Hemostasis.

Elevated levels of factor VIII and subsequent risk of all‐cause mortality: results from the MEGA follow‐up study

F. Rosendaal, S. Cannegieter, L. Flinterman, 2015, Journal of thrombosis and haemostasis : JTH.

High levels of coagulation factors and venous thrombosis risk: strongest association for factor VIII and von Willebrand factor

P. Reitsma, S. Cessie, F. Rosendaal, 2018, Journal of thrombosis and haemostasis : JTH.

Hypertensive Complications of Pregnancy and Risk of Venous Thromboembolism

C. D. de Groot, S. Middeldorp, S. Cannegieter, 2020, Hypertension.

Venous and arterial thrombosis in dialysis patients

F. Dekker, F. Rosendaal, R. Krediet, 2011, Thrombosis and Haemostasis.

Risk factors of arterial cardiovascular complications in patients with prior venous thromboembolism.

M. Prins, H. Büller, K. Hamulýak, 2011, The Netherlands journal of medicine.

Contribution of high factor VIII, IX and XI to the risk of recurrent venous thrombosis in factor V Leiden carriers

F. Rosendaal, S. Cannegieter, S. Christiansen, 2009, Journal of thrombosis and haemostasis : JTH.

Venous thromboembolism in HIV-positive women during puerperium: a case series.

J. van der Meer, H. Sprenger, W. Lijfering, 2006, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Risk and Risk Factors Associated With Recurrent Venous Thromboembolism Following Surgery in Patients With History of Venous Thromboembolism

S. le Cessie, I. Schipper, F. Rosendaal, 2019, JAMA network open.

Thromboprophylaxis after hospital discharge in acutely ill medical patients: need for trials in patients who are at high risk of venous thrombosis.

S. Cannegieter, W. Lijfering, B. Nemeth, 2017, Journal of thoracic disease.

Risk of venous thrombosis in persons with increased body mass index and interactions with other genetic and acquired risk factors

F. Rosendaal, S. Cannegieter, W. Lijfering, 2016, Journal of thrombosis and haemostasis : JTH.

Increased risk of venous thrombosis in persons with clinically diagnosed superficial vein thrombosis: results from the MEGA study.

F. Rosendaal, S. Cannegieter, W. Lijfering, 2011, Blood.

Association between deep vein thrombosis and transient inflammatory signs and symptoms: a case–control study

W. Lijfering, J. Kluin-Nelemans, Y. Tichelaar, 2010, Journal of thrombosis and haemostasis : JTH.

Different risk of deep vein thrombosis and pulmonary embolism in carriers with factor V Leiden compared with non-carriers, but not in other thrombophilic defects. Results from a large retrospective family cohort study

M. Prins, H. Büller, K. Hamulýak, 2010, Haematologica.

Recurrent venous thrombosis related to overweight and obesity: results from the MEGA follow‐up study

F. Rosendaal, S. Cannegieter, W. Lijfering, 2017, Journal of thrombosis and haemostasis : JTH.

Effect of lower‐leg trauma and knee arthroscopy on procoagulant phospholipid‐dependent activity

J. Hansen, R. Nelissen, S. Cannegieter, 2022, Research and practice in thrombosis and haemostasis.

Coagulation factor levels in relation to venous thrombosis and cancer: Results from the MEGA study

S. Cessie, F. Rosendaal, H. Versteeg, 2016 .

Relationship between cytomegalovirus infection and procoagulant changes in human immunodeficiency virus-infected patients.

H. Sprenger, W. Lijfering, R. Mulder, 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Statin use decreases coagulation in users of vitamin K antagonists

M. Kruip, F. V. D. van der Meer, W. Lijfering, 2016, European Journal of Clinical Pharmacology.

The risk of venous thrombosis in individuals with a history of superficial vein thrombosis and acquired venous thrombotic risk factors.

F. Rosendaal, S. Cannegieter, A. van Hylckama Vlieg, 2013, Blood.

The Risk of Venous Thrombosis Related to Increase in Body Mass Index Is Mediated by Factor VIII Induced APC-Resistance.

F. Rosendaal, S. Cannegieter, S. Christiansen, 2009 .

A Replication Study of Gene Variants Associated with Venous Thrombosis. Results From a Population-Based Nested Case-Cohort Study.

F. Rosendaal, S. Cannegieter, S. Christiansen, 2009 .

Metformin use decreases the anticoagulant effect of phenprocoumon

W. Lijfering, F. J. M. Meer, J. Wijnen, 2014, Journal of thrombosis and haemostasis : JTH.

Factor V levels and risk of venous thrombosis: The MEGA case‐control study

P. Reitsma, F. Rosendaal, R. Li-Gao, 2018, Research and practice in thrombosis and haemostasis.

Risk of cardiovascular disease in double heterozygous carriers and homozygous carriers of F5 R506Q (factor V Leiden) and F2 (prothrombin) G20210A: a retrospective family cohort study

M. Prins, H. Büller, K. Hamulýak, 2011, British journal of haematology.

Absolute risk of venous and arterial thrombosis in HIV‐infected patients and effects of combination antiretroviral therapy

J. van der Meer, H. Sprenger, W. Lijfering, 2006, Journal of thrombosis and haemostasis : JTH.

Decreased free protein S levels and venous thrombosis in the acute setting, a case-control study.

H. Kluin-Nelemans, K. Meijer, A. Mulder, 2011, Thrombosis research.

Opioid Prescription Patterns and Risk Factors Associated With Opioid Use in the Netherlands

A. Dahan, M. Bouvy, F. Rosendaal, 2019, JAMA network open.

Active cytomegalovirus infection in patients with acute venous thrombosis: A case‐control study

H. Kluin-Nelemans, H. Sprenger, W. Lijfering, 2011, American journal of hematology.

Relationship between Venous and Arterial Thrombosis: A Review of the Literature from a Causal Perspective

J. Vandenbroucke, F. Rosendaal, S. Cannegieter, 2011, Seminars in thrombosis and hemostasis.

Major bleeding risks of different low‐molecular‐weight heparin agents: a cohort study in 12 934 patients treated for acute venous thrombosis

P. Reitsma, M. Kruip, S. Cannegieter, 2017, Journal of thrombosis and haemostasis : JTH.

Increased risk of major bleeding after a minor bleed during treatment with vitamin K antagonists is determined by fixed common risk factors

P. Reitsma, S. Cessie, S. Cannegieter, 2016, Journal of thrombosis and haemostasis : JTH.

Rosuvastatin use reduces thrombin generation potential in patients with venous thromboembolism: a randomized controlled trial

F. Rosendaal, F. Leebeek, M. Kruip, 2019, Journal of thrombosis and haemostasis : JTH.

Relationship between progression to AIDS and thrombophilic abnormalities in HIV infection.

J. van der Meer, H. Sprenger, W. Lijfering, 2008, Clinical chemistry.

The relationship between body mass index, activated protein C resistance and risk of venous thrombosis

F. Rosendaal, S. Cannegieter, S. Christiansen, 2012, Journal of thrombosis and haemostasis : JTH.

Apolipoproteins A1, B, and apoB/apoA1 ratio are associated with first ST-segment elevation myocardial infarction but not with recurrent events during long-term follow-up

J. Jukema, M. Schalij, F. Rosendaal, 2018, Clinical Research in Cardiology.

Validation of risk assessment models for venous thrombosis in hospitalized medical patients

S. Cannegieter, W. Lijfering, B. Nemeth, 2019, Research and Practice in Thrombosis and Haemostasis.

Why crowding matters in the time of COVID-19 pandemic? - a lesson from the carnival effect on the 2017/2018 influenza epidemic in the Netherlands

F. Rosendaal, W. Lijfering, M. D. de Boer, 2020, BMC Public Health.

Hematologic variables and venous thrombosis: red cell distribution width and blood monocyte count are associated with an increased risk

F. Rosendaal, S. Cannegieter, S. Rezende, 2014, Haematologica.

Hematological variables and venous thrombosis : red cell distribution width and blood monocytes are associated with an increased risk Running title : RDW , monocytes and venous thrombosis

F. Rosendaal, S. Cannegieter, S. Rezende, 2013 .

Sex difference in the risk of recurrent venous thrombosis: a detailed analysis in four European cohorts

F. Rosendaal, T. Baglin, R. Tait, 2015, Journal of thrombosis and haemostasis : JTH.

Protein S levels and the risk of venous thrombosis: results from the MEGA case-control study.

P. Reitsma, F. Rosendaal, C. Doggen, 2013, Blood.

Increased risk of CVD after VT is determined by common etiologic factors.

F. Rosendaal, S. Cannegieter, L. Flinterman, 2013, Blood.

Prolonged activation of nasal immune cell populations and development of tissue-resident SARS-CoV-2 specific CD8 T cell responses following COVID-19

J. Goeman, R. Tsonaka, T. Hankemeier, 2021, medRxiv.

Switching from vitamin K antagonists to direct oral anticoagulants: Treatment satisfaction and patient concerns

M. Huisman, S. Cannegieter, W. Lijfering, 2020, Journal of thrombosis and haemostasis : JTH.

Predictors, time course, and outcomes of persistence patterns in oral anticoagulation for non-valvular atrial fibrillation: a Dutch Nationwide Cohort Study

S. Cannegieter, W. Lijfering, Qingui Chen, 2021, European heart journal.

Differential risks in men and women for first and recurrent venous thrombosis: the role of genes and environment

S. Cannegieter, W. Lijfering, R. Roach, 2014, Journal of thrombosis and haemostasis : JTH.

Risk factors for venous thrombosis – current understanding from an epidemiological point of view

F. Rosendaal, S. Cannegieter, W. Lijfering, 2010, British journal of haematology.

Can we prevent venous thrombosis with statins: an epidemiologic review into mechanism and clinical utility

F. Rosendaal, F. Leebeek, M. Kruip, 2016, Expert review of hematology.

Antibiotic use as a marker of acute infection and risk of first and recurrent venous thrombosis

S. Cessie, S. Braekkan, F. Rosendaal, 2017, British journal of haematology.

Lipid levels and risk of venous thrombosis: results from the MEGA-study

F. Rosendaal, S. Cannegieter, W. Lijfering, 2017, European Journal of Epidemiology.

Carotid Atherosclerosis Predicts Future Myocardial Infarction But Not Venous Thromboembolism: The Tromsø Study

J. Hansen, E. Mathiesen, I. Njølstad, 2014, Arteriosclerosis, thrombosis, and vascular biology.

Repeated measurements of carotid atherosclerosis and future risk of venous thromboembolism: the Tromsø Study

E. Mathiesen, I. Njølstad, S. Johnsen, 2017, Journal of thrombosis and haemostasis : JTH.

Influence of rosuvastatin on apolipoproteins and coagulation factor levels: Results from the STAtin Reduce Thrombophilia trial

F. Leebeek, M. Kruip, S. Cannegieter, 2023, Research and practice in thrombosis and haemostasis.

Skin Autofluorescence Is Associated With 5-Year Mortality and Cardiovascular Events in Patients With Peripheral Artery Disease

Pieter W Kamphuisen, Clark J Zeebregts, A. Smit, 2014, Arteriosclerosis, thrombosis, and vascular biology.

Glucose metabolism affects coagulation factors: The NEO study

F. Rosendaal, R. Mutsert, W. Lijfering, 2019, Journal of thrombosis and haemostasis : JTH.

Statin Therapy to Revert Hypercoagulability and Prevent Venous Thromboembolism: A Narrative Review

S. Cannegieter, W. Lijfering, F. Orsi, 2019, Seminars in Thrombosis and Hemostasis.

Procoagulant factors and future risk of arterial cardiovascular disease in patients with prior venous thrombosis: A cohort study

F. Rosendaal, S. Cannegieter, J. F. Timp, 2023, EJHaem.

Impact of Venous Thromboembolism on the Formation and Progression of Carotid Atherosclerosis: The Tromsø Study

J. Hansen, E. Mathiesen, I. Njølstad, 2017, TH Open.

Statin use and risk of recurrent venous thrombosis: results from the MEGA follow‐up study

S. le Cessie, F. Rosendaal, S. Cannegieter, 2017, Research and practice in thrombosis and haemostasis.

Role of Hemostatic Factors on the Risk of Venous Thrombosis in People With Impaired Kidney Function

F. Dekker, F. Rosendaal, G. Ocak, 2014, Circulation.

Comparison of Two Different Analgesic Prescription Strategies and Healthcare Systems: Slovenia vs. the Netherlands

A. Dahan, F. Rosendaal, M. Niesters, 2021, Frontiers in Pain Research.

A Rapid (Differential) Effect of Rosuvastatin and Atorvastatin on High‐Sensitivity Cardiac Troponin‐I in Subjects With Stable Cardiovascular Disease

N. Sattar, J. Jukema, S. Bergheanu, 2018, Clinical pharmacology and therapeutics.

Are retired physicians suitable for the coaching of clerks?

W. Lijfering, M. Wijnen-Meijer, I. Bank, 2017, International journal of medical education.

Stability of vitamin K antagonist anticoagulation after COVID‐19 diagnosis

S. Cannegieter, F. V. D. van der Meer, W. Lijfering, 2021, Research and Practice in Thrombosis and Haemostasis.

Current and future burden of venous thrombosis: Not simply predictable

S. Cannegieter, W. Lijfering, L. Scheres, 2018, Research and practice in thrombosis and haemostasis.

A lower risk of recurrent venous thrombosis in women compared with men is explained by sex-specific risk factors at time of first venous thrombosis in thrombophilic families.

M. Prins, H. Büller, J. van der Meer, 2009, Blood.

High long-term absolute risk of recurrent venous thromboembolism in patients with hereditary deficiencies of protein S, protein C or antithrombin

H. Kluin-Nelemans, J. van der Meer, N. Veeger, 2008, Thrombosis and Haemostasis.

Possible contribution of cytomegalovirus infection to the high risk of (recurrent) venous thrombosis after renal transplantation

S. Bakker, A. Vries, N. Veeger, 2007, Thrombosis and Haemostasis.

Mesenteric vein thrombosis associated with primary cytomegalovirus infection: a case report.

J. van der Meer, W. V. van Son, H. Sprenger, 2007, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Sex Difference in Risk of Second but Not of First Venous Thrombosis: Paradox Explained

S. le Cessie, F. Rosendaal, S. Cannegieter, 2014, Circulation.

Quality of life and fear of cancer recurrence in T1 colorectal cancer patients treated with endoscopic or surgical tumor resection.

K. Peeters, L. Moons, W. Lijfering, 2019, Gastrointestinal endoscopy.

Vitamin supplementation on the risk of venous thrombosis: results from the MEGA case-control study.

F. Rosendaal, S. Cannegieter, W. Lijfering, 2015, The American journal of clinical nutrition.

Genetic variants of F11, statin use and venous thrombosis

F. Rosendaal, J. Devlin, L. Bare, 2011, Journal of thrombosis and haemostasis : JTH.

High levels of glucose at time of diagnosing venous thrombosis: a case‐control study

K. Meijer, W. Lijfering, J. Kluin-Nelemans, 2011, Journal of thrombosis and haemostasis : JTH.

Seasonal variation of venous thrombosis: a consecutive case series within studies from Leiden, Milan and Tromsø

S. Braekkan, F. Rosendaal, I. Martinelli, 2012, Journal of thrombosis and haemostasis : JTH.

Bloodcurdling movies and measures of coagulation: Fear Factor crossover trial

F. Rosendaal, W. Lijfering, L. Scheres, 2015, British Medical Journal.

Hyperhomocysteinemia is not a risk factor for venous and arterial thrombosis, and is associated with elevated factor VIII levels.

M. Prins, H. Büller, J. van der Meer, 2008, Thrombosis research.

Influence of World Thrombosis Day on digital information seeking on venous thrombosis: a Google Trends study

S. Middeldorp, S. Cannegieter, W. Lijfering, 2016, Journal of thrombosis and haemostasis : JTH.

Adherence to direct oral anticoagulant treatment for atrial fibrillation in the Netherlands: A surveillance study

F. Rosendaal, F. Klok, M. Huisman, 2021, Pharmacoepidemiology and drug safety.

Self‐reported therapy adherence and predictors for nonadherence in patients who switched from vitamin K antagonists to direct oral anticoagulants

M. Huisman, S. Cannegieter, F. V. D. van der Meer, 2020, Research and practice in thrombosis and haemostasis.

Persistence of oral anticoagulant treatment for atrial fibrillation in the Netherlands: A surveillance study

F. Rosendaal, F. Klok, M. Huisman, 2019, Research and practice in thrombosis and haemostasis.

Trigger Factors for Spontaneous Intracerebral Hemorrhage: A Case-Crossover Study

S. Cannegieter, M. Wermer, W. Lijfering, 2021, Stroke.

Pharmacological Prevention of Venous Thromboembolism

W. Lijfering, J. Meer, 2009 .

Opioid prescribing patterns after arthroplasty of the knee and hip: a Dutch nationwide cohort study from 2013 to 2018

A. Dahan, M. Bouvy, F. Rosendaal, 2022, Acta orthopaedica.

Time Trends in Patient Characteristics, Anticoagulation Treatment, and Prognosis of Incident Nonvalvular Atrial Fibrillation in the Netherlands

S. Cannegieter, W. Lijfering, L. Tops, 2023, JAMA network open.

Persistence to direct oral anticoagulants for acute venous thromboembolism.

F. Klok, M. Huisman, S. Cannegieter, 2018, Thrombosis research.

The Immediate Effect of COVID-19 Vaccination on Anticoagulation Control in Patients Using Vitamin K Antagonists

M. Kruip, S. Cannegieter, F. V. D. van der Meer, 2021, Blood.

The Immediate Effect of COVID-19 Vaccination on Anticoagulation Control in Patients Using Vitamin K Antagonists

M. Kruip, S. Cannegieter, F. V. D. van der Meer, 2021, Thrombosis and Haemostasis.

Suspected survivor bias in case-control studies: stratify on survival time and use a negative control.

P. Reitsma, F. Rosendaal, S. Cannegieter, 2014, Journal of clinical epidemiology.

Determinants of impaired renal and vascular function are associated with elevated levels of procoagulant factors in the general population

H. Lamb, S. le Cessie, J. Jukema, 2018, Journal of thrombosis and haemostasis : JTH.

The Risk for Venous Thrombosis in Patients with Increased Body Mass Index and Interactions with Other Genetic and Acquired Risk Factors: The MEGA Study

F. Rosendaal, S. Cannegieter, W. Lijfering, 2011 .

Selective Serotonin Reuptake Inhibitor Use and Risk of Major Bleeding during Treatment with Vitamin K Antagonists: Results of A Cohort Study

M. Kruip, F. V. D. van der Meer, W. Lijfering, 2022, Thrombosis and Haemostasis.

“Effect of polypharmacy on bleeding with rivaroxaban versus vitamin K antagonist for treatment of venous thromboembolism”: Comment

W. Lijfering, 2022, Journal of thrombosis and haemostasis : JTH.

A. Dahan, F. Rosendaal, W. Lijfering, 2022, BMJ open gastroenterology.

The risk of venous and arterial thrombosis in hyperhomocysteinaemia is low and mainly depends on concomitant thrombophilic defects

M. Prins, H. Büller, J. van der Meer, 2007, Thrombosis and Haemostasis.

Venous and arterial thromboembolism after colorectal cancer in the Netherlands: Incidence, predictors, and prognosis.

Q. Chen, H. Versteeg, F. Klok, 2023, Thrombosis research.

[Case-crossover studies. Research into risk factors with the patient as his or her own control].

B. Siegerink, W. Lijfering, R. Roach, 2013, Nederlands tijdschrift voor geneeskunde.

Associations between high factor VIII and low free protein S levels with traditional arterial thrombotic risk factors and their risk on arterial thrombosis: results from a retrospective family cohort study.

H. Kluin-Nelemans, B. Mahmoodi, S. Middeldorp, 2010, Thrombosis research.

H. Kluin-Nelemans, B. Mahmoodi, J. Brouwer, 2010, Journal of thrombosis and haemostasis : JTH.

Correction: Prediction of recurrent venous thrombosis in all patients with a first venous thrombotic event: The Leiden Thrombosis Recurrence Risk Prediction model (L-TRRiP)

S. le Cessie, J. Hansen, S. Braekkan, 2021, PLoS medicine.

Bacillus Calmette-Gu (cid:1) erin vaccine for prevention of COVID-19 and other respiratory tract infections in older adults with comorbidities: a randomized controlled trial

M. A. van den Bosch, J. H. van de Wijgert, W. Boersma, 2022 .

Coffee consumption is associated with a reduced risk of venous thrombosis that is mediated through hemostatic factor levels

S. le Cessie, F. Rosendaal, S. Cannegieter, 2012, Journal of thrombosis and haemostasis : JTH.

Low absolute risk of venous and arterial thrombosis in hyperhomocysteinaemia – A prospective family cohort study in asymptomatic subjects

M. Prins, H. Büller, S. Middeldorp, 2008, Thrombosis and Haemostasis.

Differential risks in men and women for first and recurrent venous thrombosis: the role of genes and environment: reply

S. Cannegieter, W. Lijfering, R. Roach, 2015, Journal of thrombosis and haemostasis : JTH.